Fails 2 of 8 criteria. S3, pharmacy identification: The pages say prescriptions are filled by 503A pharmacies and ship from licensed U.S. partner pharmacies, and no pharmacy is named in the answers, the footer, the terms, the return policy or the telehealth consent. 1 more criterion also fails; see the table below.
At a glance
LifeRx MDTelehealth service
6/8criteria passed
Price
Semaglutide $200 for a 5-week supply, NAD+ from $150 a month
Sells
compounded GLP-1 (contains semaglutide), NAD+ injection, and 3 more
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A New Jersey telehealth service selling a compounded semaglutide program at one price for a five-week supply with the provider visit included, NAD+ as an injection or nasal spray, and erectile dysfunction and hair loss medication. Care starts with a booked appointment and a video visit, and no filling pharmacy is named.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA licensed provider in the buyer's state reviews the intake and medical history and decides whether treatment is right, and an initial video consultation is required for weight loss treatment. The terms say providers are engaged by independent medical groups.Source: LifeRx MD's FAQ; LifeRx MD's terms of use page.
S2PASSThe start and buy buttons on the GLP-1 pages open an appointment booking form that connects the buyer with a licensed provider to review goals and medical history, and no cart or payment screen comes before it. The answers place the intake and a video visit before treatment.Source: LifeRx MD's GLP-1 weight loss page; LifeRx MD's get started page; LifeRx MD's FAQ.
S3FAILThe pages say prescriptions are filled by 503A pharmacies and ship from licensed U.S. partner pharmacies, and no pharmacy is named in the answers, the footer, the terms, the return policy or the telehealth consent.Source: LifeRx MD's FAQ; LifeRx MD's weight loss page; LifeRx MD's terms of use page; LifeRx MD's returns policy; LifeRx MD's telehealth consent.
S4PASSThe GLP-1 pages state beside the price that the compounded drugs have not been approved by the FDA or reviewed by it for safety, effectiveness or quality, and that FDA-approved products containing semaglutide are available.Source: LifeRx MD's GLP-1 weight loss page; LifeRx MD's weight loss page.
S5FAILThe NAD+ page describes a 99%+ pure USP-grade formulation, and no certificate of analysis or lot document is published on the product pages, the answers or the policies.Source: LifeRx MD's NAD+ injection page; LifeRx MD's FAQ.
S6PASSLifeRx MD Inc. at 401 Cooper Landing Rd # C1, Cherry Hill, NJ 08002, printed in the footer of every page and in the terms and the privacy policy.Source: LifeRx MD's website; LifeRx MD's terms of use page; LifeRx MD's privacy policy.
S7PASSCompounded GLP-1 containing semaglutide at $200 for a 5-week supply, with the provider consult, medication and supplies included and the same price at every dose. The NAD+ injection at $150.00 a month for 200 mg and the NAD+ nasal spray at $150.00 a month, while the cross-sell card on each of those two pages prints the other product from $180 a month.Source: LifeRx MD's GLP-1 weight loss page; LifeRx MD's weight loss page; LifeRx MD's NAD+ injection page; LifeRx MD's NAD+ nasal spray page; LifeRx MD's metabolic wellness page.
S8PASSNo FDA warning letter names LifeRx or LifeRx MD Inc., and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded GLP-1 (contains semaglutide), NAD+ injection, NAD+ nasal spray, sildenafil, tadalafil, vardenafil and avanafil, minoxidil, finasteride and spironolactone hair treatments.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.